Johnson & Johnson JNJ
i
Market dataready · fetched 2026-11-06T14:20:42.215Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T14:16:33.883593216Z
FundamentalsSEC EDGAR · ready · as of 2026-09-27 · fetched 2026-11-06T14:20:41.636827+00:00
Johnson & Johnson options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 281.40 | 42.4% | 6.0% | 260.02 | 24.3% | 3.0% |
| 25Δ | 279.19 | 44.4% | 5.4% | 261.73 | 22.9% | 2.5% |
| 30Δ | 277.09 | 46.5% | 4.9% | 263.17 | 21.9% | 2.1% |
| 35Δ | 274.85 | 47.9% | 4.4% | 264.41 | 21.0% | 1.7% |
| 40Δ | 272.75 | 50.4% | 4.0% | 265.50 | 20.1% | 1.4% |
| 45Δ | 270.53 | 53.2% | 3.7% | 266.45 | 19.1% | 1.2% |
| 50Δ | 268.11 | 55.8% | 3.3% | 267.40 | 18.2% | 0.9% |
| 55Δ | 265.45 | 59.5% | 3.0% | 268.10 | 17.1% | 0.8% |
| 60Δ | 262.39 | 64.5% | 2.8% | 268.76 | 16.0% | 0.6% |
| 65Δ | 258.62 | 70.9% | 2.5% | 269.43 | 14.9% | 0.4% |
| 70Δ | 253.69 | 80.5% | 2.3% | |||
| 75Δ | 246.05 | 98.7% | 2.3% | |||
| 80Δ | 234.16 | 126.8% | 2.2% | |||
20Δ
- Pseudo strike
- 281.40
- IV
- 42.4%
- B/E move
- 6.0%
- Pseudo strike
- 260.02
- IV
- 24.3%
- B/E move
- 3.0%
25Δ
- Pseudo strike
- 279.19
- IV
- 44.4%
- B/E move
- 5.4%
- Pseudo strike
- 261.73
- IV
- 22.9%
- B/E move
- 2.5%
30Δ
- Pseudo strike
- 277.09
- IV
- 46.5%
- B/E move
- 4.9%
- Pseudo strike
- 263.17
- IV
- 21.9%
- B/E move
- 2.1%
35Δ
- Pseudo strike
- 274.85
- IV
- 47.9%
- B/E move
- 4.4%
- Pseudo strike
- 264.41
- IV
- 21.0%
- B/E move
- 1.7%
40Δ
- Pseudo strike
- 272.75
- IV
- 50.4%
- B/E move
- 4.0%
- Pseudo strike
- 265.50
- IV
- 20.1%
- B/E move
- 1.4%
45Δ
- Pseudo strike
- 270.53
- IV
- 53.2%
- B/E move
- 3.7%
- Pseudo strike
- 266.45
- IV
- 19.1%
- B/E move
- 1.2%
50Δ
- Pseudo strike
- 268.11
- IV
- 55.8%
- B/E move
- 3.3%
- Pseudo strike
- 267.40
- IV
- 18.2%
- B/E move
- 0.9%
55Δ
- Pseudo strike
- 265.45
- IV
- 59.5%
- B/E move
- 3.0%
- Pseudo strike
- 268.10
- IV
- 17.1%
- B/E move
- 0.8%
60Δ
- Pseudo strike
- 262.39
- IV
- 64.5%
- B/E move
- 2.8%
- Pseudo strike
- 268.76
- IV
- 16.0%
- B/E move
- 0.6%
65Δ
- Pseudo strike
- 258.62
- IV
- 70.9%
- B/E move
- 2.5%
- Pseudo strike
- 269.43
- IV
- 14.9%
- B/E move
- 0.4%
70Δ
- Pseudo strike
- 253.69
- IV
- 80.5%
- B/E move
- 2.3%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 246.05
- IV
- 98.7%
- B/E move
- 2.3%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 234.16
- IV
- 126.8%
- B/E move
- 2.2%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 24.54% | |
| 23.42% | |
| 23.12% | |
| 23.82% | |
| 20.09% | |
| 23.74% | |
| 24.44% | |
| 23.80% | |
| 23.71% | |
| 21.56% | |
| 22.86% | |
| 22.60% | |
| 22.68% | |
| 22.98% | |
| 20.96% | |
| 21.69% | |
| 22.15% | |
| 23.86% | |
| 21.97% | |
| 20.83% | |
| 24.26% | |
| 24.19% | |
| 23.40% | |
| 21.82% | |
| 23.57% | |
| 27.08% | |
| 24.25% | |
| 24.21% | |
| 23.03% | |
| 24.32% | |
| 25.69% | |
| 25.26% | |
| 24.82% | |
| 24.49% | |
| 26.44% | |
| 26.27% | |
| 25.95% | |
| 25.46% | |
| 24.78% | |
| 27.90% | |
| 27.22% | |
| 27.75% | |
| 28.80% | |
| 28.29% | |
| 32.91% | |
| 27.77% | |
| 24.98% | |
| 25.91% | |
| 24.27% | |
| 24.64% | |
| 25.62% | |
| 25.48% | |
| 28.34% | |
| 24.71% | |
| 26.60% | |
| 25.96% | |
| 26.59% | |
| 25.44% | |
| 26.38% |
Drug Manufacturers - General
LLY
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125…
More →MRK
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in…
More →NVO
Description unavailable
More →NVS
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
More →OGN
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine,…
More →PFE
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company…
More →